Clinical Trials List
2020-06-26 - 2026-12-31
Phase I/II
Recruiting6
ICD-10C16.9
Malignant neoplasm of stomach, unspecified
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.9
Malignant neoplasm of stomach, unspecified
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/14
Investigators and Locations
Co-Principal Investigator
- Chung-Pin Li Digestive System Department
- Yun-Cheng Hsieh Digestive System Department
- 姜乃榕 Division of Hematology & Oncology
- Yee Chao Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
- Chien-An Liu Division of Others -
- Rheun-Chuan Lee Division of Radiation Therapy
- Yi-Ping Hung Division of Hematology & Oncology
- Shao-Jung Hsu Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chi Chou Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
- 吳教恩 Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- Chia-Hsun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yan-Shen Shan Division of General Surgery
- 劉奕廷 Division of Hematology & Oncology
- Yung-Yeh Su Division of Hematology & Oncology
- 趙盈瑞 Division of Hematology & Oncology
- Chia-Jui Yen Division of General Internal Medicine
- Hui-Jen Tsai Division of Hematology & Oncology
- Chien-Jui Huang Division of Hematology & Oncology
- Chih-Chieh Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭明濬 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- 賴香蘭 Division of Hematology & Oncology
- Shau-Hsuan Li Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kun-Huei Yeh Division of Hematology & Oncology
- Hsin-Yu Liu Division of Ophthalmology
- Hsiang-Fong Kao Division of General Internal Medicine
- 陳國興 Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
463 participants
